FDA Inspection
F.H. Investments Inc.F.H. Investments Inc. – FDA Inspection, Nov 8, 2024
Record Details
This FDA Inspection record concerns F.H. Investments Inc., with an inspection on November 8, 2024, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · 4ae01936-487c-445f-b345-54f83e18632f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1255751
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.167(c)Controlled release dosage form testing
- 21 CFR 211.42(c)(5)Mfg / Processing Operations Area
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of F.H. Investments Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 10, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for F.H. Investments Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.